Company intelligence / Profile preview
Boffin Biotech
- Ownership
- Private
- Employees
- ~26
- Development stage
- Other
Overview
Boffin Biotech manufactures and supplies over 100 pharmaceutical formulations, including tablets, capsules, creams, ointments, and oral suspensions, across a broad range of therapeutic areas. Products are distributed to both semi-regulated and non-regulated global markets, and the company maintains GMP-compliant facilities with in-house R&D and testing labs[1][5][9].
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesGastroenterologyDermatologyCardiovascularNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on Boffin Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boffin Biotech.